Catherine Fortpied

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

John Raemaekers, Marc André, Massimo Federico et al. · Journal of Clinical Oncology · 2014 · 383 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

EORTC elderly task force position paper: Approach to the older cancer patient

A.G. Pallis, Catherine Fortpied, Ulrich Wedding et al. · European Journal of Cancer · 2010 · 340 citations

Medicine, Oncology, Radiation Oncology +12

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

Philip Poortmans, Caroline Weltens, Catherine Fortpied et al. · The Lancet Oncology · 2020 · 288 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

Anne‐Ségolène Cottereau, Annibale Versari, Annika Loft et al. · Blood · 2018 · 189 citations · Full text

Medicine, Hematology, Oncology +11